Mid Atlantic Financial Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.12M Buy
28,917
+2,508
+9% +$287K 0.21% 105
2021
Q2
$2.98M Sell
26,409
-193
-0.7% -$21.7K 0.2% 109
2021
Q1
$2.88M Buy
26,602
+1,457
+6% +$156K 0.21% 103
2020
Q4
$2.69M Buy
25,145
+1,434
+6% +$138K 0.21% 110
2020
Q3
$2.25M Sell
23,711
-1,179
-5% -$111K 0.2% 113
2020
Q2
$2.44M Buy
24,890
+772
+3% +$68K 0.24% 92
2020
Q1
$1.84M Buy
24,118
+1,019
+4% +$86.8K 0.21% 102
2019
Q4
$2.04M Sell
23,099
-1,352
-6% -$112K 0.19% 114
2019
Q3
$1.85M Sell
24,451
-3,569
-13% -$245K 0.2% 102
2019
Q2
$2.04M Buy
28,020
+4,510
+19% +$354K 0.21% 104
2019
Q1
$1.9M Buy
23,510
+1,562
+7% +$128K 0.21% 99
2018
Q4
$2.02M Buy
+21,948
New +$1.93M 0.25% 88

Other funds holding ABBV

Mid Atlantic Financial Management's ABBV Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its AbbVie (ABBV) stake by 9.5% in Q3 2021, buying an estimated $287K and bringing the position to 28,917 shares worth $3.12M. The position accounts for 0.21% of the portfolio, ranked #105.

Mid Atlantic Financial Management first reported a position in ABBV in Q4 2018 and has held it in 12 quarters since. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Mid Atlantic Financial Management held 28,917 shares of AbbVie worth $3.12M as of Q3 2021.
  • Mid Atlantic Financial Management bought 2,508 AbbVie shares in Q3 2021, an estimated $287K.
  • AbbVie made up 0.21% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #105 holding.
  • Mid Atlantic Financial Management first reported a position in AbbVie in Q4 2018 and has held it in 12 quarters since.
  • 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.